Chemical synthesis of [des(tetrapeptide B27--30), Tyr(NH2)26-B] and [des(pentapeptide B26--30), Phe(NH2)25-B] bovine insulins.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International journal of peptide & protein research

• Publication date

  2009-01-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1399-3011.1979.TB01957.XPMID 395118
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [21-arginine-A] insulin: a biologically active analog.

  2009cited by this paper
• Synthesis of des(tetrapeptide B(1-4)) and des(pentapeptide B(1-5)) human insulins. Two biologically active analogues.

  1978cited by this paper
• The synthesis of peptides by homogeneous solution procedures.

  1977cited by this paper
• Further studies on the three-step-increase in activity due to the aromatic amino acids B24-26 (-Phe-Phe-Tyr-).

  1976cited by this paper
• Receptor-binding region of insulin

  1976cited by this paper
• Synthesis of human [9-leucine-B] Insulin.

  1976cited by this paper
• B-Kettenverkürzung von polymergebundenem Insulin mit Pepsin, I. Darstellung und Eigenschaften von Des-Pentapeptid (B26-30)-Rinderinsulin

  1975cited by this paper
• [B-chain shortening of matrix-bound insulin by pepsin, I:Preparation and properties of bovine des-pentapeptide(B26-30) insulin (suthor's transl)].

  1975cited by this paper
• Synthesis of a biologically active truncated insulin. Des(pentapeptide B23-30) human (porcine) insulin.

  1974cited by this paper
• Synthesis of destetrapeptide B27-30 human (porcine) insulin. A biologically active insulin analog.

  1973cited by this paper
• Insulin peptides. Part XXIV. A novel synthesis of the human insulin B chain S-sulphonate

  1973cited by this paper
• Insulin peptides. Part XXIII. The synthesis of a hexadecapeptide derivative related to the B chain of human insulin

  1973cited by this paper
• Analogs of insulin. 1. Synthesis of destripeptide B 28-30 bovine insulin and destripeptide B 28-30 porcine (human) insulin.

  1971cited by this paper
• Structure of Rhombohedral 2 Zinc Insulin Crystals

  1969cited by this paper
• Verbesserte Synthese von tert.-Butyloxycarbonyl-aminosäuren durch pH-Stat-Reaktion

  1967cited by this paper
• Studies on the synthesis of insulin from natural and synthetic A and B chains. I. Splitting of insulin and isolation of the S-sulfonated derivatives of the A and B chains.

  1967cited by this paper
• Studies on the synthesis of insulin from natural and synthetic A and B chains. II. Isolation of insulin from recombination mixtures of natural A and B chains.

  1967cited by this paper
• Studies on the synthesis of insulin from natural and synthetic A and B chains. 3. Synthetic insulins.

  1967cited by this paper
• [Improved synthesis of etert-butyloxycarbonyl-amino acids through pH stable reactions].

  1967cited by this paper
• Eine neue Synthese der Α-Kette des Schafinsulins und deren Vereinigung mitnatürlicher B-Kette zu kristallinem, vollaktivem Insulin 1, 2

  1966cited by this paper
• Synthèse de la désamino1-Arg8-vasopressine et de la désamino1-Phe2-Arg8-vasopressine, deux analogues possédant une activité antidiurétique plus élevée et plus sélective que celle des vasopressines naturelles†

  1966cited by this paper
• Insulin synthesis by recombination of A and B chains: a highly efficient method.

  1966cited by this paper
• Synthèse d'analogues structuraux de l'élédoïsine. 1re partie: Préparation des produits intermédiaires

  1963cited by this paper
• Neue Methoden zur Herstellung von Carbonsäure-arylestern. Über aktivierte Ester VIII†

  1957cited by this paper

• Facile synthesis of insulin fusion derivatives through sortase A ligation

  2020cites this paper
• A thing of beauty: Structure and function of insulin's “aromatic triplet”

  2018cites this paper
• Patent Number : 45 Date of Patent : 54 SUPERACTIVE HUMAN INSULIN ANALOGUES

  2017cites this paper
• Contribution of TyrB26 to the Function and Stability of Insulin

  2016cites this paper
• Protective hinge in insulin opens to enable its receptor engagement

  2014cites this paper
• Discovery of high potency, single-chain insulin analogs with a shortened B-chain and nonpeptide linker.

  2013cites this paper
• Design of ultra-stable insulin analogues for the developing world

  2013cites this paper
• Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering

  2011cites this paper
• Enhancing the Activity of a Protein by Stereospecific Unfolding

  2009cites this paper
• [12-asparagine-B] human insulin. An analogue with modification in the hydrophobic core of insulin.

  2009cites this paper
• Structure-function relationships of des-(B26-B30)-insulin.

  2009cites this paper
• Insulin structure and function.

  2007cites this paper
• Insulin: a model system for nanomedicine?

  2006cites this paper
• Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama.

  2005cites this paper
• Diabetes-associated mutations in insulin identify invariant receptor contacts.

  2004cites this paper
• How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor.

  2004cites this paper
• Acute metabolic actions of des-(B27–B30)-insulin and related analogues in adult rats

  2004cites this paper
• Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.

  2004cites this paper
• How Insulin Binds: the B-Chain α-Helix Contacts the L1 β-Helix of the Insulin Receptor

  2004cites this paper
• Crystal structure of allo-Ile(A2)-insulin, an inactive chiral analogue: implications for the mechanism of receptor binding.

  2003cites this paper
• Exploring the foldability and function of insulin by combinatorial peptide chemistry

  2002cites this paper
• Chiral mutagenesis of insulin's hidden receptor-binding surface: structure of an allo-isoleucine(A2) analogue.

  2002cites this paper
• Protein structure and the spandrels of San Marco: insulin's receptor-binding surface is buttressed by an invariant leucine essential for its stability.

  2002cites this paper
• Mini-proinsulin and mini-IGF-I: homologous protein sequences encoding non-homologous structures.

  1998cites this paper
• Inactive conformation of an insulin despite its wild‐type sequence

  1997cites this paper
• Contribution of the B16 and B26 tyrosine residues to the biological activity of insulin

  1993cites this paper
• Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.

  1991cites this paper
• Structure and activity of the B-chain of insulin.

  1989cites this paper
• A highly potent insulin: des-(B26-B30)-[AspB10,TyrB25-NH2]insulin(human).

  1989cites this paper
• Mutation of the high cysteine region of the human insulin receptor alpha-subunit increases insulin receptor binding affinity and transmembrane signaling.

  1989cites this paper
• Shortened insulin with enhanced in vitro potency.

  1987cites this paper
• Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.

  1986cites this paper
• A shortened insulin with full in vitro potency.

  1985cites this paper
• Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A]insulin.

  1980cites this paper